Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351423

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351423

Compounding Pharmacies Market, By Product Type, By Application, By Therapeutic areas, By Compounding Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 248 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Compounding pharmacies have a unique and crucial function in the pharmaceutical sector. By blending, modifying, or combining two or more substances to match a patient's unique needs, pharmacists create customized prescriptions for their patients. In order to create a compounded medicine, compounding pharmacies must use only pure, pharmaceutical-grade ingredients. These have to be manufactured in a setting that has an FDA registration. Compound and conventional medications are labeled differently in several cases. unlike labels for FDA-approved pharmaceuticals, compounded medicine labels don't adhere to a specific structure. The laws governing them differ as well.

Compounding Pharmacies Market - Market Dynamics:

  • Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand
  • Long-term treatment is frequently necessary for chronic disorders. Compounding pharmacies can adapt pharmaceuticals to a patient's unique requirements, maximizing dosages and forms, or otherwise improving their effectiveness or tolerability for patients with particular demands. According to the National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. There is a greater need for specialist geriatric care as there are more senior people, both in terms of medical services and facilities designed for this age group. The emphasis on preventative medicine to ensure quality of life grows as life expectancy rises. This may strengthen the wellness, nutrition, and screening industries. Significant opportunity for development is offered by developing nations. The need for customized treatments could increase as awareness and income levels improve in these areas. However, the severe regulatory supervision that compounding pharmacies occasionally experience can be problematic. It hampers the market growth.

Compounding Pharmacies Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Compounding Pharmacies market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
  • The Compounding Pharmacies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Therapeutic Area segmentation, Hormone Replacement Therapy (HRT) was the leading type in 2022
  • Based on Application segmentation, Geriatric was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Compounding Pharmacies Market- Segmentation Analysis:

  • The Global Compounding Pharmacies Market is segmented based on Product Type, Therapeutic Areas, Application, Compounding Type, and Region.
  • The market is divided into seven categories based on product type: Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. The oral segment dominates the market. Due to its ease of administration, patient compliance, and diversity in formulation (such as tablets, capsules, liquids, and suspensions), the oral route remains one of the most popular drug delivery modalities.
  • The market is divided into four categories based on Therapeutic Areas: Pain Management, Hormone Replacement Therapy (HRT), Dermatology, and Specialty Drugs. Hormone Replacement Therapy (HRT) segment dominates the market. Compounding pharmacies play an important part in the field of Hormone Replacement Therapy (HRT). HRT is the use of hormones to treat hormonal abnormalities in the body, which are frequently associated with menopause, andropause (sometimes known as "male menopause"), or certain endocrine illnesses.
  • The market is divided into four categories based on Application: Pediatric, adult, Geriatric, and Veterinary. The Geriatric application dominates the market and is likely to maintain its dominance during the forecast period. Compounding pharmacies play an important part in the geriatric healthcare sector. Because of factors such as polypharmacy (taking numerous medications), age-related physiological changes, specific drug sensitivities, and drug administration problems, the aged population frequently has unique prescription needs.

Compounding Pharmacies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to High regional awareness regarding compounding medications, and an increasing number of healthcare facilities. Over the years, the US and Canada have made considerable investments in healthcare infrastructure. This covers not only hospitals but also specialty clinics, nursing homes, and other care settings where compounded pharmaceuticals can be beneficial. The U.S. Health Care from a Global Perspective predicted that in 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Europe is the second-largest market for Compounding Pharmacies, due to high awareness, regulatory clarity, economic strength, and technological innovation.

Compounding Pharmacies Market- Competitive Landscape:

As with many sectors, the competitive landscape of the compounding pharmacies industry is defined by the existence of many main players, regional players, and local, independent pharmacies. These organizations frequently compete on the basis of quality, service range, regulatory compliance, technical improvements, and geographic coverage. The market share will differ depending on the location and the precise niche within compounding that each company occupies. In terms of revenue, larger businesses with several locations may dominate, although local, independent pharmacies may hold major shares in local marketplaces.

Some pharmacies may use technology improvements to improve compounding precision, quality control, or operational efficiency. For Example, Avella Specialty Pharmacy has signed a definitive agreement to acquire Houston-based Advanced Pharma Inc., an FDA-registered 503B outsourcing facility providing compounded products across 14 therapeutic classes to hospitals, health systems, and ambulatory surgery centers nationwide.

Recent Developments:

On Oct. 11, 2018, Fresenius Kabi announced currently it has opened a new pharmaceutical compounding center in Mississauga, Ontario. The center features state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and increased capacity needs of customers. The facility produces compounded pharmaceuticals for Canadian hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy

GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE

  • Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
  • Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
  • Rectal
  • Parenteral
  • Nasal
  • Ophthalmic
  • Mouthwashes

GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Dermatology
  • Specialty Drugs

GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

  • Pediatric
  • Adults
  • Geriatric
  • Veterinary

GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

  • Pharmaceutical Ingredient Alteration (PIA)
  • Pharmaceutical Dosage Alteration (PDA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA
Show more
Product Code: ANV1658

Table of Contents

1. Compounding Pharmacies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Compounding Pharmacies Market Snippet by Product Type
    • 2.1.2. Compounding Pharmacies Market Snippet by Application
    • 2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
    • 2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
    • 2.1.5. Compounding Pharmacies Market Snippet by Country
    • 2.1.6. Compounding Pharmacies Market Snippet by Region
  • 2.2. Competitive Insights

3. Compounding Pharmacies Key Market Trends

  • 3.1. Compounding Pharmacies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Compounding Pharmacies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Compounding Pharmacies Market Opportunities
  • 3.4. Compounding Pharmacies Market Future Trends

4. Compounding Pharmacies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Compounding Pharmacies Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Compounding Pharmacies Market Landscape

  • 6.1. Compounding Pharmacies Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Compounding Pharmacies Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
      • 7.1.2.1. Capsule
      • 7.1.2.2. Tablets
      • 7.1.2.3. Mixtures
      • 7.1.2.4. Lollipops
      • 7.1.2.5. Lozenges
    • 7.1.3. Topical
      • 7.1.3.1. Gels
      • 7.1.3.2. Ointments
      • 7.1.3.3. Cream
      • 7.1.3.4. Lotions
    • 7.1.4. Rectal
    • 7.1.5. Parenteral
    • 7.1.6. Nasal
    • 7.1.7. Ophthalmic
    • 7.1.8. Mouthwashes

8. Compounding Pharmacies Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Pediatric
    • 8.1.3. Adults
    • 8.1.4. Geriatric
    • 8.1.5. Veterinary

9. Compounding Pharmacies Market - By Compounding Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Ingredient Alteration (PIA)
    • 9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 9.1.4. Pharmaceutical Dosage Alteration (PDA)
    • 9.1.5. Others

10. Compounding Pharmacies Market - By Therapeutic Areas

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Pain Management
    • 10.1.3. Hormone Replacement Therapy (HRT)
    • 10.1.4. Dermatology
    • 10.1.5. Specialty Drugs

11. Compounding Pharmacies Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Compounding Pharmacies Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Compounding Pharmacies Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Compounding Pharmacies Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Avella Specialty Pharmacy
    • 12.2.2. Central Admixture Pharmacy Services
    • 12.2.3. Fagron
    • 12.2.4. Fresenius Kabi AG
    • 12.2.5. PharMEDium Services
    • 12.2.6. Institutional Pharmacy Solutions
    • 12.2.7. Cantrell Drug Company
    • 12.2.8. Triangle Compounding Pharmacies
    • 12.2.9. Lorraine's Pharmacy
    • 12.2.10. Rx3 Compounding Pharmacy
    • 12.2.11. B Braun Melsungen AG
    • 12.2.12. Clinigen Group PLC
    • 12.2.13. QuVa Pharma
    • 12.2.14. ITC Compounding Pharmacy
    • 12.2.15. Advanced Pharmacy.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
Show more
Product Code: ANV1658

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Compounding Pharmacies Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Compounding Pharmacies Market, by Product Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Compounding Pharmacies Market, by Application 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Compounding Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Compounding Type
  • TABLE Global Compounding Pharmacies Market, by Compounding Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Therapeutic Areas Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Compounding Pharmacies Market, by Therapeutic Areas 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Compounding Pharmacies Market, by Region 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)

List of Figures

  • FIGURE Compounding Pharmacies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Compounding Type segment market share analysis, 2022 & 2030
  • FIGURE Compounding Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapeutic Areas segment market share analysis, 2022 & 2030
  • FIGURE Therapeutic Areas segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Europe Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Asia Pacific Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Latin America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Middle East and Africa Compounding Pharmacies Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Germany Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE India Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Brazil Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Saudi Arabia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!